Cataract News and Research

Latest Cataract News and Research

Research roundup: The effects of health IT, doctor-owned treatment centers, long-term care issues

Physician-Ownership Of Ambulatory Surgery Centers Linked To Higher Volume Of Surgeries - The authors analyzed data from Florida, using the Healthcare Cost and Utilization Project's State Ambulatory Surgery Databases, revealing "a significant association between physician-ownership of surgicenters and greater use" of certain outpatient procedures.

9 Apr 2010

LensAR receives patent for using laser technology to increase flexibility of ocular lens

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.

8 Apr 2010

Financial stake in surgery centers motivates doctors to operate more often

When doctors become invested in an outpatient surgery center, they perform on average twice as many surgeries as doctors with no such financial stake, according to a new study from the University of Michigan Health System.

7 Apr 2010

Vision CRC scientists discover new technology to control myopia

Scientists from the Vision Cooperative Research Centre in Australia today announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners - the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.

31 Mar 2010

Research Roundup: Middle class health cost burden, disparities and cancer, summary of new health law

The Growing Financial Burden Of Health Care: National And State Trends, 2001-2006 - This paper examines the ratio of total out-of-pocket spending for health care and insurance to total family income, using data from the Medical Expenditure Panel Surveys for 2001-2006.

26 Mar 2010

Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV

Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.

26 Mar 2010

Oramed Pharmaceuticals completes Phase 2b study of ORMD-0801 oral insulin capsule

Oramed Pharmaceuticals Inc. announced today the completion of its' pivotal Phase 2b clinical study of its oral insulin capsule, ORMD-0801. The Company expects to report results from this study within the coming weeks.

26 Mar 2010

Special medicated contact lenses can help treat common eye disorders

The popular dietary supplement vitamin E, loaded into special medicated contact lenses, can keep glaucoma medicine near the eye - where it can treat that common disease- almost 100 times longer than possible with current commercial lenses, scientists reported here today.

25 Mar 2010

Financial incentives may influence frequency of cataract surgery in Medicare and VA health system

Patients seen at private facilities reimbursed by Medicare were more than 550 percent more likely to have routine cataract surgery than those who received their care from the Department of Veterans Affairs, a strong indication that the frequency of cataract surgery may be responsive to financial incentives to either or both the medical facility and the physicians who perform the procedure.

19 Mar 2010

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Manitobans with wet age-related macular degeneration (AMD) received a dose of good news. The Manitoba government announced that Lucentis (ranibizumab injection) will soon be funded through a centralized vision program, effective June 1, 2010.

18 Mar 2010

OVD issue highlights prevalence of eye problems in general population

In the latest issue of Optometry & Vision Development (OVD), Dr. Dominick Maino, editor of OVD, notes that: "In 2010 there are 9 million people with lazy eye and 18 million individuals with eye-turns

17 Mar 2010

$TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers$

TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers

OccuLogix, Inc., dba TearLab Corporation, announced today that TLCVision Corporation, North America's premier eye care services company, will be incorporating the TearLab™ Osmolarity System in eight of its U.S. refractive surgery centers to study Dry Eye Disease symptoms as they relate to LASIK surgery.

11 Mar 2010

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

Abbott announced today it has received U.S. Food and Drug Administration approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia.

10 Mar 2010

Some anti-depressant drugs associated with increased chance of developing cataracts: Study

Some anti-depressant drugs are associated with an increased chance of developing cataracts, according to a new statistical study by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute and McGill University.

9 Mar 2010

ISTA Pharmaceuticals' sNDA for once-daily XiDay: FDA assigns PDUFA action date

ISTA Pharmaceuticals, Inc., today announced the Company's supplemental New Drug Application (sNDA) for once-daily XiDay™ (bromfenac ophthalmic solution) has been accepted for review by the U.S. Food and Drug Administration (FDA).

8 Mar 2010

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the positive top-line results reported in December 2009 by pSivida and its licensee, Alimera Sciences, Inc.

4 Mar 2010

Patient Safety Authority highlights analysis of data related to insulin medication errors

Pennsylvania healthcare facilities submitted over 2,600 event reports that involved the use of insulin products to the Patient Safety Authority where more than 52 percent led to situations in which a patient may have or actually received the wrong dose or no dose of insulin. The data raises awareness of a broader issue that is highlighted in the 2010 March Pennsylvania Patient Safety Advisory.

3 Mar 2010

Advances in surgical technology enable surgeons to perform many operations as outpatient procedures

Nearly 58 percent of the surgeries performed in hospitals were done as outpatient procedures, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

26 Feb 2010

Alcon reports 2009 fourth quarter results

Alcon, Inc. reported that global sales rose 14.5 percent to $1.72 billion for the fourth quarter of 2009, or an 8.5 percent increase excluding the impact of foreign exchange fluctuations. Reported net earnings for the fourth quarter of 2009 grew 8.0 percent to $458 million, or $1.51 per diluted share.

11 Feb 2010

Cholesterol lowering drugs also reduce risk of developing cataracts

Statins, a class of drugs used to lower cholesterol levels, have been successfully fighting heart disease for years. A new study from Tel Aviv University has now found that the same drugs cut the risks of cataracts in men by almost 40%.

10 Feb 2010

Cataract News and Research

Latest Cataract News and Research

Research roundup: The effects of health IT, doctor-owned treatment centers, long-term care issues

LensAR receives patent for using laser technology to increase flexibility of ocular lens

Financial stake in surgery centers motivates doctors to operate more often

Vision CRC scientists discover new technology to control myopia

Research Roundup: Middle class health cost burden, disparities and cancer, summary of new health law

Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV

Oramed Pharmaceuticals completes Phase 2b study of ORMD-0801 oral insulin capsule

Special medicated contact lenses can help treat common eye disorders

Financial incentives may influence frequency of cataract surgery in Medicare and VA health system

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

OVD issue highlights prevalence of eye problems in general population

TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

Some anti-depressant drugs associated with increased chance of developing cataracts: Study

ISTA Pharmaceuticals' sNDA for once-daily XiDay: FDA assigns PDUFA action date

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

Patient Safety Authority highlights analysis of data related to insulin medication errors

Advances in surgical technology enable surgeons to perform many operations as outpatient procedures

Alcon reports 2009 fourth quarter results

Cholesterol lowering drugs also reduce risk of developing cataracts

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Cataract News and Research

Latest Cataract News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in